Latest TRV news and sentiment

Pallas Capital Advisors LLC Acquires New Holdings in The Travelers Companies, Inc. $TRV

Pallas Capital Advisors LLC has acquired 6,266 shares of The Travelers Companies, Inc. (NYSE:TRV) during the second quarter, valued at approximately $2.07 million. The insurance provider reported strong quarterly earnings, beating analyst estimates with an EPS of $10.04 and revenue of $12.15 billion. Despite some insider selling, analysts maintain a consensus "Hold" rating for TRV with an average price target of $354.26, and the company also declared a quarterly dividend of $1.25 per share.

Trust Co. of Vermont Purchases Shares of 6,280 The Travelers Companies, Inc. $TRV

Trust Co. of Vermont recently acquired 6,280 shares of The Travelers Companies, Inc. (NYSE:TRV) during the second quarter, a new position valued at approximately $2.07 million. Institutional investors now own 82.45% of the insurer's stock. Travelers reported strong quarterly earnings, significantly beating analyst estimates, and declared a dividend of $1.25 per share.

Plato Investment Management Ltd Acquires Shares of 6,253 The Travelers Companies, Inc. $TRV

Plato Investment Management Ltd recently acquired 6,253 shares of The Travelers Companies, Inc. (NYSE:TRV) for approximately $2.05 million. This move is part of broader institutional investment activity, with other hedge funds also adjusting their positions in the insurance provider. The article also details recent insider stock sales, analyst rating changes, and the company's latest financial performance, including its quarterly earnings beat and upcoming dividend.

Global Retirement Partners LLC Takes $1.78 Million Position in The Travelers Companies, Inc. $TRV

Global Retirement Partners LLC has acquired a new stake of 5,389 shares, valued at $1.78 million, in The Travelers Companies, Inc. during the second quarter. This move comes as other institutional investors have also adjusted their positions in TRV, and analysts have set various price targets, with a consensus "Hold" rating. Additionally, the article notes recent insider stock sales by Travelers executives and financial details including the company's dividend announcement and Q2 earnings beat.

Resilient Travelers Companies stock holds around $370 as strong earnings and institutional demand sh

Travelers Companies (TRV) stock is trading around $370, supported by a significant earnings beat and increased institutional investment. The company reported quarterly EPS of $10.04 against an estimate of $5.41 and revenue of $12.15 billion, exceeding expectations. TRV also declared a quarterly dividend of $1.25, and its year-to-date performance shows a 27.7% increase, indicating strong investor confidence despite analysts' "Hold" rating.

R.H. Investment Group LLC Buys Shares of 20,186 The Travelers Companies, Inc. $TRV

Longfellow Investment Management Co. LLC Takes $1.40 Million Position in The Travelers Companies, Inc. $TRV

Longfellow Investment Management Co. LLC has acquired a new stake of 4,249 shares in The Travelers Companies, Inc. (NYSE:TRV), valued at approximately $1.40 million. This comes as other institutional investors have also adjusted their positions in the insurance provider. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $1.25 per share.

4,223 Shares in The Travelers Companies, Inc. $TRV Purchased by HBK Sorce Advisory LLC

HBK Sorce Advisory LLC recently purchased 4,223 shares of The Travelers Companies, Inc. (TRV) for approximately $1.62 million, marking a new position for the firm. This comes as Travelers reported strong quarterly earnings of $10.04 per share, significantly surpassing analyst expectations, and declared a quarterly dividend of $1.25 per share. Despite the strong financial performance, analysts currently maintain a "Hold" rating for the stock with a consensus price target below its current trading price.

Travelers Expands Product Liability Product to California Life Sciences

Travelers has expanded its Synergy product liability insurance for life sciences companies to California, making it available in all 50 states. This product is designed to protect against product-related claims throughout the development lifecycle, offering core coverage for bodily injury and property damage, with optional add-ons like errors and omissions liability and product recall expenses. Travelers also introduced a broader sales professional liability coverage for life sciences sales representatives working in clinical settings.

Travelers Companies stock holds above $370 as earnings beat lifts outlook

Travelers Companies Inc. (TRV) stock is trading above $370 after reporting strong quarterly earnings of $10.04 per share, significantly beating analyst estimates. This performance, driven by underwriting discipline rather than rapid revenue growth, highlights the insurer's robust profitability and efficient use of capital. While the stock trades above consensus target prices, its stable performance, dividend payments, and strategic expansion into specialized insurance lines like product liability for life sciences continue to attract investors.

AMG National Trust Bank Makes New $1.15 Million Investment in The Travelers Companies, Inc. $TRV

AMG National Trust Bank has initiated a new position in The Travelers Companies, Inc. (NYSE:TRV), purchasing 3,487 shares valued at approximately $1.15 million in the second quarter. This move comes as other institutional investors have also adjusted their holdings in the insurance provider. The article also details recent analyst ratings, insider selling activities, the company's strong price performance, and a recently declared quarterly dividend.

1ST Source Bank Invests $4.48 Million in The Travelers Companies, Inc. $TRV

1ST Source Bank recently acquired a new stake of 13,562 shares, valued at $4.48 million, in The Travelers Companies, Inc. Institutional investors and hedge funds collectively own 82.45% of TRV. The Travelers Companies reported strong quarterly earnings of $10.04 EPS, significantly beating consensus estimates, and declared a quarterly dividend of $1.25 per share.

Travelers Companies stock holds above $370 as earnings beat lifts outlook

Travelers Companies Inc. (TRV) stock is trading above $370 after reporting strong quarterly earnings of $10.04 per share, significantly beating analyst estimates. This performance, driven by underwriting discipline rather than rapid revenue growth, highlights the insurer's robust profitability and efficient use of capital. While the stock trades above consensus target prices, its stable performance, dividend payments, and strategic expansion into specialized insurance lines like product liability for life sciences continue to attract investors.

Focus Partners Advisor Solutions LLC Buys New Stake in The Travelers Companies, Inc. $TRV

Focus Partners Advisor Solutions LLC has acquired a new stake of 9,521 shares in The Travelers Companies, Inc. (NYSE:TRV) during the second quarter, valued at approximately $3.14 million. This article details institutional investor activity, insider transactions, stock performance metrics, and recent analyst ratings for Travelers Companies. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.